CTSO
Cytosorbents Corp
Key Financials
Net Income
$-8198000
↑ 60.4%
Gross Profit
$26.5M
↑ 5.4%
EPS (Diluted)
$-0.13
↑ 65.8%
Operating Income
$-14749000
↑ 12.1%
Revenue
$22.5M
↑ 270.1%
Total Assets
$44.2M
↓ 6.7%
Total Liabilities
$38.3M
↑ 5.6%
Cash & Equivalents
$6.2M
↑ 90.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 6/25/2026 | View on SEC |
| DEFA14A | 6/25/2026 | View on SEC |
| DEF 14A | 6/25/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
| PRE 14A | 6/11/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 10-K/A | 4/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTSO |
| Company Name | Cytosorbents Corp |
| CIK | 1175151 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-329-8885 |